Low-molecular-weight heparins for deep vein thrombosis - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Low-molecular-weight heparins for deep vein thrombosis - [Medication] - Quest Diagnostics Patient Health Library Low-molecular-weight heparins for deep vein thrombosis - [Medication] - Quest Diagnostics Patient Health Library anti-thrombotics, antithrombotic...
Anticoagulants for aortic and mitral valve regurgitation - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Anticoagulants for aortic and mitral valve regurgitation - [Medication] - Quest Diagnostics Patient Health Library Anticoagulants for aortic and mitral valve regurgitation - [Medication] - Quest Diagnostics Patient Health Library AI, Anti-clotting drugs,...
CPG_GazetteCover_0529.qxd DOLPHIN Current Patents Gazette Patenting in Context The UK Patents and Design Journal (PDJ No.danaparoid sodium (Orgaran) extending the life of JP2655746 to November 2013.Orgaran, an antithrombotic, has been discontinued in the US....
author: AGregory
CPG_GazetteCover_0529.qxd page 1
author: AGregory
Drug Approvals - O Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted Ocufen Ophthalmic Solution, (0.03%) Allergan NDA 19-404/S020 8/25/03 8/28/03 8/28/03 - Ocufen Ophthalmic Solution (0.03%) Allergan NDA 19-404/S017 8/17/01 - 4/15/03 - Ocufen Ophthalmic Solution (0.03%) Allergan NDA 19-404/S014 7/30/01 - 4/15/03 - Ofloxacin Injection, 40 mg/mL packaged in 10 mL...
Drug Shortages FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - Drug Shortages - Introduction FAQs Current Drug Shortages - Resolved Drug Shortages Drugs to be Discontinued - Drug Shortage Manual of Policies and Procedures (MaPP) Medical Necessity Guidance Document How to Report a Drug Shortage - Practical Steps for Practitioners Facing Shortage...
http://www.fda.gov/cder/orange/appendix_a.txt IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, BACITRACIN ZINC NEOSPORIN, GRAMICIDIN NEOSPORIN, NEOMYCIN SULFATE (OTC) NEOTHYLLINE, DYPHYLLINE NEOTRIZINE, TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE; SULFAMETHAZINE) NEPHRAMINE 5.4%, AMINO ACIDS NEPHROFLOW, IODOHIPPURATE SODIUM, I-123 NEPTAZANE, METHAZOLAMIDE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE...
20-430_Orgaran.htm Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Orgaran (Danaparoid Sodium) Injection Company:--Organon, Inc
author: Paul Stauffer
Reference Listed Drug Labeling Approved in June 2001 Jun 1 CEFAZOLIN AND DEXTROSE letter label cefazolin for injection/dextrose injection 50-779 S-001 Jun 5 LIMBITROL DS letter label chlordiazepoxide/amitriptyline HCl tablets 16-949 S-033 ZEMURON letter label rocuronium bromide injection 20-214 S-013 Jun 6 MENTAX letter label butenafine HCl cream 20-524 S-005 Jun 8 INTEGRILIN letter label eptifibatide injection 20-718 S-013 LIPITOR...
author: USERNAME
http://www.fda.gov/cder/reports/cderfact.pdf page 23
author: Carolyn Spencer
http://www.fda.gov/cder/reports/cderfact.pdf pylori detection kit Manufacturer SmithKline Beecham Organon Lilly Pharmacia and Upjohn Boehringer Ingelheim Zeneca Gilead Glaxo Wellcome Hoechst Marion Roussel Parke Davis Enviroderm Advanced Magnetics Allergan Meretek Generic Name albendazole mirtazapine lispro irinotecan HCl nevirapine meropenen cidofovir remifentanil HCl fexofenadine HCl fosphenytion sodium bentoquatam...
author: Carolyn Spencer
FDA Drug Approvals List June 2001 Catarrhalis (including B-lactamase-producing strains) Original Application #: 021224 Approval Date: 22-JUN-01 Trade Name: REMINYL Chemical Type: 3 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: JANSSEN RESEARCH FDN Active Ingredient(s): GALANTAMINE HYDROBROMIDE OTC/RX Status: RX Indication(s): For the treatment of mild to moderate dementia of the Alzheimer's type Original...
Prescription and OTC Drug Product List 6/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- AA PEACHTREE 500MG;10MG N40210 001 AUG 13, 1997 JUN CAHN -A- AA UCB 500MG;10MG N40210 001 AUG 13, 1997 JUN CAHN ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE TABLET; ORAL DARVOCET -A- @ AAIPHARMA LLC 325MG;32.5MG N16844 001 JUN CAHN -D- @...
Conversions UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
author: Bowne
Conversions page 6
author: Bowne
duplicates:http://www.tbc.com/content/2000ar10k.pdf
Low Molecular Weight Heparins (LMWHs) in Emergency Practice Trouble navigating this site
August | Hot Topics in Healthcare Trouble navigating this site
Marketed Products Celltech Products ...
C:\Data\My Documents\NDA20430-S-003-06-25-01-AP.doc page 2
author: Karen Oliver
C:\Data\My Documents\NDA20430-S-003-06-25-01-AP.doc page 1
author: Karen Oliver
FDA Drug Approvals List- January 1998 PHARMACEUTICALS DIVISION Active Ingredient(s): PERMETHRIN OTC/RX Status: RX Original Abbreviated Application # 040219 Approval Date: 22-JAN-98 Trade Name: OXYCODONE AND ACETAMINOPHEN Dosage Form: CAPSULE Applicant: HALSEY DRUG CO INC Active Ingredient(s): ACETAMINOPHEN; OXYCODONE OTC/RX Status: RX Original Abbreviated Application # 074815 Approval Date: 20-JAN-98 Trade Name:...
FDA DRUG AND DEVICE PRODUCT APPROVALS 19-815 PROAMATINE ROBERTS PHARM MIDODRINE HYDROCHLORIDE 06-JUN-96 (TABLET) EATONTOWN, NJ 2.5MG 07724 5MG (ANTIHYPOTENSIVE) 20-519 LOPROX HOECHST MARION RSSL CICLOPIROX 02-JUL-96 (GEL) BRIDGEWATER, NJ 0.77% 08807 (ANTIFUNGAL) 20-584 LODINE XL WYETH AYERST ETODOLAC 03-JUL-96 (TABLET, PHILADELPHIA, PA 400MG EXTENDED RELEASE) 19101 600MG (NONSTEROIDAL ANTI-INFLAMMATORY) 20-453 PANDEL...
Drug Approvals December 1996 Drug Approvals for December 1996 Definitions and Notes December 1996 Original New Drug Applications Original Application #: 020681 Approval Date: 31-DEC-96 Trade Name: ORTHO TRI-CYCLEN Chemical Type: 6 Therapeutic Potential: S Dosage Form: TABLET Applicant: RW JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE DIV ORTHO PHARMACEUTICAL CORP Active Ingredient(s): ETHINYL ESTRADIOL; NORGESTIMATE...
July Drug Approvals Drug Approvals for July 1996 Definitions and Notes Original New Drug Application Original Application #: 020538 Approval Date: 31-JUL-96 Trade Name: ESTRADIOL Chemical Type: Already marketed drug product but a new manufacturer Therapeutic Potential: Standard review drug Dosage Form: FILM, EXTENDED RELEASE Applicant: MENOREST MANFACTURING INC Active Ingredient(s): ESTRADIOL OTC/RX...
1996 and Older - New Drug Application (NDA) New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office
